0
Correspondence |

Bronchoscopy for Refractory AsthmaBronchoscopy for Refractory Asthma FREE TO VIEW

Tayyab Rehman, MD; Bennett P. deBoisblanc, MD, FCCP
Author and Funding Information

From Louisiana State University Health Sciences Center.

Correspondence to: Tayyab Rehman, MD, Louisiana State University Health Sciences Center, 1901 Perdido St, MEB, Ste 3205, New Orleans, LA 70112; e-mail: trehma@lsuhsc.edu


Financial/nonfinancial disclosures: The authors have reported to CHEST that no potential conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article.

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details.


Chest. 2012;142(3):810. doi:10.1378/chest.12-0909
Text Size: A A A
Published online

To the Editor:

We read with interest the article in CHEST (March 2012) by Good et al1 on the application of bronchoscopy to improve the management of patients with refractory asthma. In this study, patients with refractory asthma underwent bronchoscopy with the aim of (1) obtaining data to define the refractory asthma phenotypes and (2) individualizing therapy based on bronchoscopically defined refractory asthma phenotype. Outcomes measured included changes in Asthma Control Test scores and FEV1. The study reported significant improvements in these outcomes for four out of the five bronchoscopically defined phenotypes at 12 to 60 weeks postprocedure. These findings are interesting because they enhance the possibility of personalized care for patients with refractory asthma and extend the clinical usefulness of bronchoscopy. However, caution is required in interpreting these data. The lack of a separate control arm and the nonrandomized design of the trial raise the following issues:

  • 1. The role of a placebo effect in asthma was highlighted in a study by Wechsler et al,2 in which treatment with either a placebo inhaler or sham acupuncture led to equivalent improvement in subjective perception of asthma, as did treatment with active albuterol. Both placebos were superior to no intervention. It is not clear how much of the improvement in asthma control in response to bronchoscopy-directed therapy can be attributed to a placebo effect and how much to a true treatment effect.

  • 2. The subjects in the study were enrolled from the authors’ clinic. Subjects with asthma are more likely to seek an encounter with health-care providers when their disease is uncontrolled or getting out of control. Hence, a regression to the mean is likely if the same cohort is evaluated at a later time point.3 Lack of a control group limits evaluation of the true efficacy of bronchoscopy-directed care.

As a proof of principle, the findings of this study are novel, significant, and provocative. A well-designed randomized controlled trial is now required to clearly delineate the true treatment effect attributable to a bronchoscopy-directed strategy of care. Judgment on the usefulness of bronchoscopy in defining refractory asthma phenotypes and the therapeutic benefit accruing from this approach must wait until such a study has been performed.

Good JT Jr, Kolakowski CA, Groshong SD, Murphy JR, Martin RJ. Refractory asthma: importance of bronchoscopy to identify phenotypes and direct therapy. Chest. 2012;141(3):599-606. [PubMed] [CrossRef]
 
Wechsler ME, Kelley JM, Boyd IO, et al. Active albuterol or placebo, sham acupuncture, or no intervention in asthma. N Engl J Med. 2011;365(2):119-126. [PubMed] [CrossRef]
 
Tinkelman D, Wilson S. Asthma disease management: regression to the mean or better?. Am J Manag Care. 2004;10(12):948-954. [PubMed]
 

Figures

Tables

References

Good JT Jr, Kolakowski CA, Groshong SD, Murphy JR, Martin RJ. Refractory asthma: importance of bronchoscopy to identify phenotypes and direct therapy. Chest. 2012;141(3):599-606. [PubMed] [CrossRef]
 
Wechsler ME, Kelley JM, Boyd IO, et al. Active albuterol or placebo, sham acupuncture, or no intervention in asthma. N Engl J Med. 2011;365(2):119-126. [PubMed] [CrossRef]
 
Tinkelman D, Wilson S. Asthma disease management: regression to the mean or better?. Am J Manag Care. 2004;10(12):948-954. [PubMed]
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543